Barber, Kevin
Studer, Lorenz http://orcid.org/0000-0003-0741-7987
Fattahi, Faranak http://orcid.org/0000-0002-9473-8596
Article History
Received: 27 January 2016
Accepted: 15 January 2019
First Online: 25 March 2019
Competing interests
: The Memorial Sloan-Kettering Cancer Center has filed a patent application (CA3009509A1) on hPSC-derived ENC lineages for use in Hirschsprung’s disease, with L.S. and F.F. as inventors. L.S. is a co-founder and consultant of BlueRock Therapeutics.